Tg Therapeutics (TGTX) Change in Inventory (2023 - 2026)
Tg Therapeutics (TGTX) posted quarterly Change in Inventory of $13.3 million for Q1 2026, down 71.33% year-over-year from $46.3 million in Q1 2025, and up 2457.9% quarter-over-quarter from -$563000.0 in Q4 2025.
Tg Therapeutics (TGTX) Change in Inventory (2023 - 2026) Analysis & Trends
Tg Therapeutics' Change in Inventory history runs 4 years deep, the most recent figure standing at $13.3 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 71.33% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $422000.0 (down 99.45% YoY), while the FY2025 annual figure was $33.5 million, down 49.96% from the prior year.
- Change in Inventory for Q1 2026 stood at $13.3 million, up from -$563000.0 in the prior quarter.
- The five-year high for Change in Inventory was $46.3 million in Q1 2025, with the low at -$8.7 million in Q3 2025.
- The 4-year median for Change in Inventory is $2.6 million (2024), against an average of $11.6 million.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory jumped 350.78% in 2024, then tumbled 442.32% in 2025.
- Tg Therapeutics' Change in Inventory stood at $5.5 million in 2023, then surged by 350.78% to $24.8 million in 2024, then tumbled by 102.27% to -$563000.0 in 2025, then surged by 2457.9% to $13.3 million in 2026.
- Business Quant data shows TGTX's Change in Inventory at $13.3 million in Q1 2026, -$563000.0 in Q4 2025, and -$8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 66.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.82 Mn |
| Jun 30, 2026 | 66.82 Mn |
| Mar 31, 2026 | 13.28 Mn |
| Mar 31, 2026 | 13.28 Mn |
| Dec 31, 2025 | -563,000.00 |
| Dec 31, 2025 | -563,000.00 |
| Sep 30, 2025 | -8.70 Mn |
| Sep 30, 2025 | -8.70 Mn |
| Jun 30, 2025 | -3.60 Mn |
| Jun 30, 2025 | -3.60 Mn |
| Mar 31, 2025 | 46.31 Mn |
| Mar 31, 2025 | 46.31 Mn |
| Dec 31, 2024 | 24.82 Mn |
| Dec 31, 2024 | 24.82 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 36.93 Mn |
| Mar 31, 2024 | 36.93 Mn |